As expected, mutations in the AR and DNA repair genes included in our panel were the most common ones, in particular, the ATM and BRCA1/BRCA2 genes, and they seemed to drive high tumor mutation load and rapid polymetastatic spread after the first oligorecurrence treated with SBRT. This evidence concerns the gene BRCA2 and neoplasm.